Vijay Pande Advocates for Open Datasets in AI Biotech
August 29, 2026
Vijay Pande argues that biology is transitioning from discovery to engineering, requiring open, shared datasets to scale. He suggests that walled-off data silos hinder the ability of AI to transform medicine and lower clinical trial costs.
HOW THIS AFFECTS YOU
●
investorFocus on companies building in the engineering-centric biology space rather than just discovery.
●
healthYour ability to build transformative tools depends on the availability of open biological datasets.